UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 140

Sortiert nach

Pulmonary Tuberculosis Incidence among Interferon-Gamma Release Assay-Positive Individuals with Latent Tuberculosis Infection and Fibrotic Lesions in a Vulnerable Urban Population in Osaka City, Japan, 2015–2021

Japanese Journal of Infectious Diseases, 2024/01/31, Vol.77(1), pp.21-24

2024

Volltextzugriff (PDF)

Phase III Trial Comparing Oral S-1 Plus Carboplatin With Paclitaxel Plus Carboplatin in Chemotherapy-Naïve Patients With Advanced Non–Small-Cell Lung Cancer: Results of a West Japan Oncology Group Study

Journal of clinical oncology, 2010-12, Vol.28 (36), p.5240-5246

2010

Volltextzugriff (PDF)

Phase III Study of Docetaxel Compared With Vinorelbine in Elderly Patients With Advanced Non–Small-Cell Lung Cancer: Results of the West Japan Thoracic Oncology Group Trial (WJTOG 9904)

Journal of clinical oncology, 2006-08, Vol.24 (22), p.3657-3663

2006

Volltextzugriff (PDF)

Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2003-06, Vol.21 (12), p.2237-2246

2003

Volltextzugriff (PDF)

Phase III Study of Concurrent Versus Sequential Thoracic Radiotherapy in Combination With Mitomycin, Vindesine, and Cisplatin in Unresectable Stage III Non–Small-Cell Lung Cancer

Journal of clinical oncology, 1999-09, Vol.17 (9), p.2692-2699

1999

Volltextzugriff (PDF)

Reduced CYP2D6 function is associated with gefitinib-induced rash in patients with non-small cell lung cancer

BMC cancer, 2012-12, Vol.12 (1), p.568-568, Article 568

2012

Volltextzugriff (PDF)

Comparison of Docetaxel- and Vinca Alkaloid–Based Chemotherapy in the First-line Treatment of Advanced Non-small Cell Lung Cancer: A Meta-analysis of Seven Randomized Clinical Trials

Journal of thoracic oncology, 2007-10, Vol.2 (10), p.939-946

2007

Volltextzugriff (PDF)

A phase II, multicenter, single-arm trial of eribulin as first-line chemotherapy for HER2-negative locally advanced or metastatic breast cancer

SpringerPlus, 2016-02, Vol.5 (1), p.164-164, Article 164

2016

Volltextzugriff (PDF)

Randomized phase II trial of three intrapleural therapy regimens for the management of malignant pleural effusion in previously untreated non-small cell lung cancer: JCOG 9515

Lung cancer (Amsterdam, Netherlands), 2007-12, Vol.58 (3), p.362-368

2007

Volltextzugriff (PDF)

A Phase I Study of Chemoradiotherapy With Use of Involved-Field Conformal Radiotherapy and Accelerated Hyperfractionation for Stage III Non-Small Cell Lung Cancer: WJTOG 3305

International journal of radiation oncology, biology, physics, 2012-05, Vol.83 (1), p.327-331

2012

Volltextzugriff (PDF)

Molecular Epidemiological Study on Passive Smoking and Estrogen Receptor Expression in Never-smokers with Non-small Cell Lung Cancer

Osaka City medical journal, 2016-12, Vol.62 (2), p.77

2016

Volltextzugriff (PDF)

Phase II Study of Etoposide and Cisplatin With Concurrent Twice-Daily Thoracic Radiotherapy Followed by Irinotecan and Cisplatin in Patients With Limited-Disease Small-Cell Lung Cancer: West Japan Thoracic Oncology Group 9902

Journal of clinical oncology, 2006-11, Vol.24 (33), p.5247-5252

2006

Volltextzugriff (PDF)

Pulmonary Tuberculosis Incidence among Interferon-gamma Release Assays Positive Latent Tuberculosis Infection with Fibrotic Lesions in an Urban Vulnerable Population of Osaka City, Japan, 2015-2021

Japanese Journal of Infectious Diseases, 2023/09/29, pp.JJID.2023.277

2023

Volltextzugriff (PDF)

Squamous cell carcinoma presenting as a solitary growing cyst in lung: a diagnostic pitfall in daily clinical practice

Annals of thoracic and cardiovascular surgery, 2009-06, Vol.15 (3), p.174-177

2009

Volltextzugriff (PDF)

Skeletal-related events in advanced lung adenocarcinoma patients evaluated EGFR mutations

Osaka City medical journal, 2013-06, Vol.59 (1), p.45

2013

Volltextzugriff (PDF)

Phase i study of tzt-1027, a novel synthetic dolastatin 10 derivative and inhibitor of tubulin polymerization, which was administered to patients with advanced solid tumors on days 1 and 8 in 3-week courses

Cancer chemotherapy and pharmacology, 2007-07, Vol.60 (2), p.285-293

2007

Volltextzugriff (PDF)

Review of the Management of Relapsed Small-Cell Lung Cancer with Amrubicin Hydrochloride

Clinical Medicine Insights. Oncology, 2011-01, Vol.2011 (5), p.23-34

2011

Volltextzugriff (PDF)

A phase 3 study of induction treatment with concurrent chemoradiotherapy versus chemotherapy before surgery in patients with pathologically confirmed N2 stage IIIA nonsmall cell lung cancer (WJTOG9903)

Cancer, 2012-12, Vol.118 (24), p.6126-6135

2012

Volltextzugriff (PDF)

Phase II Trial of Amrubicin for Second-Line Treatment of Advanced Non-small Cell Lung Cancer: Results of the West Japan Thoracic Oncology Group Trial (WJTOG0401)

Journal of thoracic oncology, 2010-01, Vol.5 (1), p.105-109

2010

Volltextzugriff (PDF)

The Macroscopic Appearance of Computed Tomography-guided Needle Biopsy Specimens Correlates with Tumor Metastasis in Non-small Cell Lung Cancer

Osaka City medical journal, 2015-12, Vol.61 (2), p.105

2015

Volltextzugriff (PDF)

A phase II study of cisplatin and irinotecan as induction chemotherapy followed by concomitant thoracic radiotherapy with weekly low-dose irinotecan in unresectable, stage III, non-small cell lung cancer: JCOG 9706

Japanese journal of clinical oncology, 2011-01, Vol.41 (1), p.25-31

2011

Volltextzugriff (PDF)

Randomized phase III trial comparing weekly docetaxel plus cisplatin versus docetaxel monotherapy every 3 weeks in elderly patients with advanced non-small-cell lung cancer: the intergroup trial JCOG0803/WJOG4307L

Journal of clinical oncology, 2015-02, Vol.33 (6), p.575-581

2015

Volltextzugriff (PDF)

C609T Polymorphism of NADPH Quinone Oxidoreductase 1 Correlates Clinical Hematological Toxicities in Lung Cancer Patients Treated with Amrubicin

Clinical Medicine Insights. Oncology, 2013-01, Vol.2013 (7), p.31-39

2013

Volltextzugriff (PDF)

1 – 25 von 140

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(114)
Mit Volltextzugriff
(118)

Publikationsform

Artikel
(140)

Sprache

Englisch
(127)
Japanisch
(32)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(92)
Male
(89)
Science & Technology
(82)
Life Sciences & Biomedicine
(81)
Middle Aged
(73)
Female
(72)
Aged
(70)
Oncology
(65)
Lung Neoplasms - Drug Therapy
(62)
Biological And Medical Sciences
(44)
Medical Sciences
(44)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(43)
Adult
(40)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(36)
Lung Neoplasms - Pathology
(35)
Treatment Outcome
(30)
Chemotherapy
(27)
Carcinoma, Non-Small-Cell Lung - Pathology
(26)
Cisplatin - Administration & Dosage
(24)
Neoplasm Staging
(23)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pulmonary Tuberculosis Incidence among Interferon-Gamma Release Assay-Positive Individuals with Latent Tuberculosis Infection and Fibrotic Lesions in a Vulnerable Urban Population in Osaka City, Japan, 2015–2021

Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial

Phase III Trial Comparing Oral S-1 Plus Carboplatin With Paclitaxel Plus Carboplatin in Chemotherapy-Naïve Patients With Advanced Non–Small-Cell Lung Cancer: Results of a West Japan Oncology Group Study

Phase III Study of Docetaxel Compared With Vinorelbine in Elderly Patients With Advanced Non–Small-Cell Lung Cancer: Results of the West Japan Thoracic Oncology Group Trial (WJTOG 9904)

Randomized Phase III Trial of Platinum-Doublet Chemotherapy Followed by Gefitinib Compared With Continued Platinum-Doublet Chemotherapy in Japanese Patients With Advanced Non–Small-Cell Lung Cancer: Results of a West Japan Thoracic Oncology Group Trial (WJTOG0203)

Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer

Phase III Study of Concurrent Versus Sequential Thoracic Radiotherapy in Combination With Mitomycin, Vindesine, and Cisplatin in Unresectable Stage III Non–Small-Cell Lung Cancer

Reduced CYP2D6 function is associated with gefitinib-induced rash in patients with non-small cell lung cancer

Comparison of Docetaxel- and Vinca Alkaloid–Based Chemotherapy in the First-line Treatment of Advanced Non-small Cell Lung Cancer: A Meta-analysis of Seven Randomized Clinical Trials

A phase II, multicenter, single-arm trial of eribulin as first-line chemotherapy for HER2-negative locally advanced or metastatic breast cancer

Randomized phase II trial of three intrapleural therapy regimens for the management of malignant pleural effusion in previously untreated non-small cell lung cancer: JCOG 9515

A Phase I Study of Chemoradiotherapy With Use of Involved-Field Conformal Radiotherapy and Accelerated Hyperfractionation for Stage III Non-Small Cell Lung Cancer: WJTOG 3305

Molecular Epidemiological Study on Passive Smoking and Estrogen Receptor Expression in Never-smokers with Non-small Cell Lung Cancer

Phase II Study of Etoposide and Cisplatin With Concurrent Twice-Daily Thoracic Radiotherapy Followed by Irinotecan and Cisplatin in Patients With Limited-Disease Small-Cell Lung Cancer: West Japan Thoracic Oncology Group 9902

Pulmonary Tuberculosis Incidence among Interferon-gamma Release Assays Positive Latent Tuberculosis Infection with Fibrotic Lesions in an Urban Vulnerable Population of Osaka City, Japan, 2015-2021

Squamous cell carcinoma presenting as a solitary growing cyst in lung: a diagnostic pitfall in daily clinical practice

Skeletal-related events in advanced lung adenocarcinoma patients evaluated EGFR mutations

Phase i study of tzt-1027, a novel synthetic dolastatin 10 derivative and inhibitor of tubulin polymerization, which was administered to patients with advanced solid tumors on days 1 and 8 in 3-week courses

Review of the Management of Relapsed Small-Cell Lung Cancer with Amrubicin Hydrochloride

A phase 3 study of induction treatment with concurrent chemoradiotherapy versus chemotherapy before surgery in patients with pathologically confirmed N2 stage IIIA nonsmall cell lung cancer (WJTOG9903)

Phase II Trial of Amrubicin for Second-Line Treatment of Advanced Non-small Cell Lung Cancer: Results of the West Japan Thoracic Oncology Group Trial (WJTOG0401)

The Macroscopic Appearance of Computed Tomography-guided Needle Biopsy Specimens Correlates with Tumor Metastasis in Non-small Cell Lung Cancer

A phase II study of cisplatin and irinotecan as induction chemotherapy followed by concomitant thoracic radiotherapy with weekly low-dose irinotecan in unresectable, stage III, non-small cell lung cancer: JCOG 9706

Randomized phase III trial comparing weekly docetaxel plus cisplatin versus docetaxel monotherapy every 3 weeks in elderly patients with advanced non-small-cell lung cancer: the intergroup trial JCOG0803/WJOG4307L

C609T Polymorphism of NADPH Quinone Oxidoreductase 1 Correlates Clinical Hematological Toxicities in Lung Cancer Patients Treated with Amrubicin

Suchergebnisse filtern